Stay updated with breaking news from Eric Endicott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Net cash used in operating and investing activities was $31.3 million in the third quarter and $104.2 million for the first nine months of 2022; quarter-end cash and restricted cash position was
Investegate announcements from Prothena Corporation plc, Prothena Reports Second Quarter 2022 Financial Results and Business Highlights
Net cash used in operating and investing activities was $35.5 million in the second quarter and $72.9 million for the first six months of 2022; quarter-end cash and restricted cash position was $510.1
Investegate announcements from Prothena Corporation plc, Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, Ireland, July 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of novel investigational therapeutics built